Fibroblast growth factor 21 predicts arteriovenous fistula functional patency loss and mortality in patients undergoing maintenance hemodialysis

CONCLUSIONS: Serum FGF21 levels were an independent risk factor and predictor for AVF functional patency loss and all-cause mortality in patients undergoing MHD.PMID:38197433 | PMC:PMC10783836 | DOI:10.1080/0886022X.2024.2302407
Source: Renal Failure - Category: Urology & Nephrology Authors: Source Type: research